Molecular Allergen Component Resolved Diagnosis to Decide Immunotherapy

NARecruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

July 30, 2022

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions
AsthmaRhinitis, Allergic
Interventions
DIAGNOSTIC_TEST

Component resolved diagnosis

Physicians in this group will have access to allergen molecular component sensitization profile, using ImmunoCAP ISAC E112i and to all standard diagnostic tolls

DIAGNOSTIC_TEST

Standard diagnosis

Physicians will only have access to standard diagnostic tools namely skin prick tests and sIgE sensitization (not molecular IgE) and clinical history.

Trial Locations (1)

Unknown

RECRUITING

Faculty of Medicine Porto University/Centro Hospitalar de São João, Porto

All Listed Sponsors
collaborator

Sociedade Portuguesa de Alergologia e Imunologia Clinica

UNKNOWN

lead

Universidade do Porto

OTHER